{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-047844","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2023-04-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.397773+00:00","generated_at":"2026-06-16T22:30:39.457593+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TELA Bio announces public offering of 4.75M shares at $9.50 per share; expects net proceeds ~$42.1M","bullets":["Offered 4,750,000 shares at $9.50 per share; underwriters have 30-day option for 712,500 additional shares.","Net proceeds expected ~$42.1 million after underwriting discounts and estimated expenses.","Use proceeds for general corporate purposes including sales, marketing, R&D, working capital, and capex.","Offering expected to close April 21, 2023, subject to customary conditions.","Underwriting agreement with Jefferies, Piper Sandler, and Lake Street Capital Markets."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-047844","json":"https://secwatch.observer/filing/0001104659-23-047844.json","markdown":"https://secwatch.observer/filing/0001104659-23-047844.md","text":"https://secwatch.observer/filing/0001104659-23-047844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/0001104659-23-047844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/tm232660d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T22:30:39.457593+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87d17ed898a54860ff094205d5f23378e0f2393f","claim":"TELA Bio, Inc. entered into Underwriting Agreement with Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters valued at approximately $42.1 million (effective 2023-04-18).","evidence_excerpt":"On April 18, 2023, TELA Bio, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters listed in Schedule A thereto (the “ Underwriters ”) pursuant to which the Company agreed to issue and sell 4,750,000 shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), to the Underwriters (the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1561921/000110465923047844/0001104659-23-047844-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Jefferies LLC, Piper Sandler & Co. and Lake Street Capital Markets, LLC, as representatives of the several underwriters"},{"label":"Value","value":"approximately $42.1 million"},{"label":"Effective","value":"2023-04-18"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}